No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan

D. Focosi, L. Macera, E. Ciabatti, S. Galimberti, M. Petrini, A. M. Carella, M. Pistello, L. Ceccherini-Nelli, F. Maggi

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1065-1066
Number of pages2
JournalInfection
Volume42
Issue number6
DOIs
Publication statusPublished - Dec 1 2014

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Focosi, D., Macera, L., Ciabatti, E., Galimberti, S., Petrini, M., Carella, A. M., Pistello, M., Ceccherini-Nelli, L., & Maggi, F. (2014). No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan. Infection, 42(6), 1065-1066. https://doi.org/10.1007/s15010-014-0677-2